OrisDX Inc.
Health Care · Genomics & Genetic Testing
$6.8Mtotal raised · 2 rounds on record
$4Mlatest round · Seed · Jun 2025 · 17 mo ago
1backers · OCA Ventures
200+team · employees, estimated range
Overview
Detect Early, Live Fully. Our mission at OrisDX is to leverage salivary rinse samples to detect disease early and guide people to early clinical intervention through the use of next-generation testing modalities backed by cutting-edge research.
Key facts
These are the key facts about OrisDX Inc. on Alion as of Nov 13, 2026. OrisDX Inc. is headquartered in Chicago, United States. It was founded in 2022. It has raised $6.8M in 2 funding rounds. The latest round is Seed of $4M, announced in 2025.
- Headquarters
- Chicago, United StatesAlion company profile, updated Sep 28, 2026
- Founded
- 2022Alion company profile, updated Sep 28, 2026
- Employees
- 200+Alion company profile, an estimated range
- Total raised
- $6.8MSum of 2 equity rounds Alion knows
- Latest round
- Seed · $4M · Jun 10, 2025Press report · woodtv.com
Official records
Funding and backers
Total raised
$6.8M
2 rounds on record
Latest round
$4M
Seed · Jun 2025 · 17 mo ago
Team
201-500
employees, estimated range
Backers
1
OCA Ventures
The money's age
Due for its next round
17 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 8
Partnership OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection · tennessean.com
Jun 10, 2025
Raised a round Seed $4M
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Jun 2025 | $4M | — | woodtv.com |
| Venture round | May 2025 | $2.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | OrisDx Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Harald SteltzerExecutive Officer, DirectorSEC Form D
Patrick ConniffExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Clear Labs

backs Mitra Bio

backs Clear Labs

backs Clear Labs

backs Clear Labs

backs Wobble Genomics
Similar startupsby what they do, their industry and backers

Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan.

Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention…

Bullseye Biosciences is a therapeutics discovery company revolutionizing drug development through robotics and evolution. Our platform…

Fully automated, label-free sample prep on standard SBS robotics.

Clear Labs builds an FDA-cleared next-generation sequencing diagnostics platform, Clear Dx, that combines automated sample-to-report…

PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…
People

Harald Steltzer
Executive Officer, Director

Patrick Conniff
Executive Officer

Evgeny Izmchenko
Director

Nishant Agrawal
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

OCA VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chicago
United States
HQ
200-500 est. staff
How to cite this page
Alion, "OrisDX Inc.: key facts", as of Nov 13, 2026. https://alion.io/company/orisdx
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0
